Eli Lilly (LLY) EPS & PE Ratio History
Current and historical earning per share (EPS) and price to earnings (PE) ratio for Eli Lilly (LLY) over the last 10 years. The current PE ratio for Eli Lilly as of August 22, 2017 is 19.74.
|Medical||Large Cap Pharmaceutical||$85.195B||$21.222B|
|Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.|